Stifel raises target for STAAR Surgical stock to USD 31.00
Published on 10/02/2026 at 12:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
STAAR Surgical (ISIN US8523123052) was trading at EUR 19.94 at Lang & Schwarz on October 2, 2026 at 11:49 a.m. CEST, plus 0.15 percent versus the prior close of EUR 19.91. On September 29, 2026, Yahoo Finance reported that Stifel upgraded the company from Hold to Buy and raised its price target from USD 28.00 to USD 31.00.
Buyback adds a second signal
On September 24, 2026, STAAR Surgical said its board approved a share repurchase authorization of up to USD 50.00 million. The company said the program may run for twelve months and may be funded with organic free cash flow and cash on hand.
The release also stated that STAAR had no outstanding debt and USD 181.5 million in cash, cash equivalents and investments available for sale as of July 3, 2026. The authorization is discretionary, so it sets a capital-allocation framework rather than a guaranteed purchase volume.
Revenue clears the quarterly hurdle
STAAR Surgical reported USD 93.53 million in revenue for the second quarter of 2026, versus USD 90.60 million consensus, while diluted earnings per share reached USD 0.39 against USD 0.22 expected, according to MarketBeat. Revenue was 111.10 percent higher than in the year-earlier quarter, giving the recent analyst upgrade a quantified operating backdrop.
Stifel's thesis centers on higher-priced EVO+ implantable Collamer lenses in China and easier international comparisons in the second half of 2026. That view contrasts with the broader analyst picture, where MarketBeat reported four Buy ratings, six Holds and three Sells, producing a consensus Hold rating and a USD 28.45 average target on September 29, 2026.
Stock remains below its yearly high
STAAR Surgical had a USD 1.1 billion market capitalization and a USD 15.59 to USD 35.87 52-week range as of October 1, 2026. The company operates in healthcare and medical instruments and supplies, with Nasdaq as its primary exchange and STAA as its ticker.
STAAR Surgical stock facts
- Company: STAAR Surgical Company
- ISIN: US8523123052
- Ticker: STAA
- Primary exchange: Nasdaq
- Price Lang & Schwarz as of October 2, 2026 at 11:49 a.m. CEST: EUR 19.94
- Change versus prior close: plus 0.15 percent
- Prior close Lang & Schwarz October 1, 2026: EUR 19.91
- Market capitalization: USD 1.1 billion (as of October 1, 2026)
- 52-week range: USD 15.59-35.87 (as of October 1, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
